Pandion Therapeutics
Latest round
- Series B
Last raised
- Mar 2020
Total raised
- $98M
Investors
- 10
About Pandion Therapeutics
Founded in 2016 by Alan Crane, Anthony Coyle, David H. Sachs, and Jo Viney and based in Massachusetts, US, Pandion Therapeutics, Inc., known as MSD outside the US and Canada. Pandion is a clinical-stage biotechnology company that develops modular proteins, antibodies, and bispecifics to achieve therapeutic outcomes for autoimmune and inflammatory diseases. The company trades on NASDAQ under the ticker symbol, PAND.85 billion. In 2020, the company announced the pricing of its IPO of 7,500,000 shares at USD 18 per share for gross proceeds of USD 135 million. In 2020, Pandion Therapeutics, Inc. Pandion Therapeutics offers TALON™, a drug design and discovery platform to create a suite of therapies for rebalancing the immune system. Using the TALON (Therapeutic Autoimmune reguLatOry proteiN) platform, the company develops novel PD-1 agonists and other programs for systemic and tissue-targeted immune control. Pandion’s pipeline includes PT101, the drug candidate which is an interleukin 2 (IL-2) mutein Fc fusion protein therapy designed to potently and selectively expand regulatory T cells for the treatment of autoimmune diseases focused on the gut, liver, skin, kidneys, and pancreas. PT101 is currently in Phase 1a clinical trial. The TALON platform is also used for other drug candidates. The company recorded a revenue of USD 2 million for three months ended March 2020.
Who invested in Pandion Therapeutics
10 investors across 2 rounds
See all investors in Pandion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pandion Therapeutics
Who invested in Pandion Therapeutics?
Pandion Therapeutics has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pandion Therapeutics raised?
Pandion Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pandion Therapeutics last raise money?
Pandion Therapeutics's most recent round on record is a Series B, in Mar 2020.
What does Pandion Therapeutics do?
Founded in 2016 by Alan Crane, Anthony Coyle, David H.
Where is Pandion Therapeutics headquartered?
Pandion Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Pandion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pandion Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pandion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.